Granahan Investment Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3M Sell
1,661,163
-78,481
-5% -$1.04M 0.86% 31
2026
Q1
$24M Sell
1,739,644
-1,317,374
-43% -$19.9M 1.16% 24
2025
Q4
$55.1M Buy
3,057,018
+427,719
+16% +$7.68M 2.36% 8
2025
Q3
$48.7M Buy
2,629,299
+2,411,726
+1,108% +$37.9M 1.99% 12
2025
Q2
$3.48M Sell
217,573
-7,467
-3% -$133K 0.14% 117
2025
Q1
$4.37M Sell
225,040
-2,357
-1% -$49.6K 0.22% 102
2024
Q4
$5.01M Buy
227,397
+93,259
+70% +$1.79M 0.21% 106
2024
Q3
$2.26M Sell
134,138
-129,039
-49% -$1.91M 0.09% 165
2024
Q2
$3.14M Buy
263,177
+208,784
+384% +$2.33M 0.13% 152
2024
Q1
$603K Buy
+54,393
New +$555K 0.02% 174

Other funds holding CLBT

Granahan Investment Management's CLBT Position: Q2 2026 in Review

Granahan Investment Management reduced its Cellebrite (CLBT) stake by 4.5% in Q2 2026, selling an estimated $1.04M and leaving 1,661,163 shares worth $24.3M. The position accounts for 0.86% of the portfolio, ranked #31.

Granahan Investment Management first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $55.1M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Granahan Investment Management held 1,661,163 shares of Cellebrite worth $24.3M as of Q2 2026.
  • Granahan Investment Management sold 78,481 Cellebrite shares in Q2 2026, an estimated $1.04M.
  • Cellebrite made up 0.86% of Granahan Investment Management's portfolio in Q2 2026, its #31 holding.
  • Granahan Investment Management first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
  • Granahan Investment Management's Cellebrite position peaked at $55.1M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.